Citius Pharmaceuticals, Inc. reports

Company location: Cranford, NJ
Fiscal year end: 30 September

Citius Pharmaceuticals, Inc. has filed 629 SEC EDGAR filings since 23 Nov 2010

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 1-25 of 629 matching filings.

Per page

Current page

SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date: 04 Jun 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-296195

EFFECT filing

Filing date: 02 Jun 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 01 Jun 2026
Reporting date: 01 Jun 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

S-3 File 333-296195

REGISTRATION STATEMENT

Filing date: 22 May 2026
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 15 May 2026
Reporting date: 15 May 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-38174

QUARTERLY REPORT

Filing date: 15 May 2026
Reporting date: 31 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 08 May 2026
Reporting date: 04 May 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 29 Apr 2026
Reporting date: 23 Apr 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 24 Apr 2026
Reporting date: 23 Apr 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

424B5 File 333-277319

PROSPECTUS SUPPLEMENT

Filing date: 24 Apr 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 06 Apr 2026
Reporting date: 06 Apr 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 31 Mar 2026
Reporting date: 31 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 10 Mar 2026
Reporting date: 10 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 04 Mar 2026
Reporting date: 04 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

ARS File 001-38174

FORM ARS

Filing date: 24 Feb 2026
Reporting date: 30 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 001-38174

DEFINITIVE ADDITIONAL MATERIALS

Filing date: 24 Feb 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-38174

DEFINITIVE PROXY STATEMENT

Filing date: 24 Feb 2026
Reporting date: 06 Apr 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SCHEDULE 13G/A File 005-90253

SCHEDULE 13G/A filing

Filing date: 17 Feb 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 13 Feb 2026
Reporting date: 09 Feb 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-38174

QUARTERLY REPORT

Filing date: 13 Feb 2026
Reporting date: 31 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K/A File 001-38174

AMENDMENT NO. 1 TO FORM 10-K

Filing date: 28 Jan 2026
Reporting date: 30 Sep 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 23 Dec 2025
Reporting date: 23 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-38174

ANNUAL REPORT

Filing date: 23 Dec 2025
Reporting date: 30 Sep 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date: 17 Dec 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38174

CURRENT REPORT

Filing date: 01 Dec 2025
Reporting date: 01 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing